PMID- 27210091 OWN - NLM STAT- MEDLINE DCOM- 20160721 LR - 20160523 IS - 0385-0684 (Print) IS - 0385-0684 (Linking) VI - 43 IP - 5 DP - 2016 May TI - [Intraoperative BCNU Wafer Implantation for High-Grade Glioma--A Questionnaire Targeting Japanese Neurosurgeons]. PG - 603-7 AB - Carmustine (BCNU) wafer implantation has been used in Japanese patients after resection of high-grade glioma (HGG) since 2013. Wafer implantation plays an important role in improving the prognosis of HGG patients, but it often causes particular changes as observed on neuroimaging and various adverse effects (AEs). Here, we conducted a questionnaire-based survey of Japanese neurosurgeons to determine how they feel about this treatment based on their actual observations. Most neurosurgeons had a positive impression of the treatment based on previous evidence of clinical effectiveness. Additionally, we found that the Japanese neurosurgeons are taking measures to cope with some AEs including cerebral edema, postoperative convulsions, cerebrospinal fluid leakage, and protracted wound healing. FAU - Ishikawa, Eiichi AU - Ishikawa E AD - Dept. of Neurosurgery, University of Tsukuba. FAU - Yamamoto, Tetsuya AU - Yamamoto T LA - jpn PT - English Abstract PT - Journal Article PL - Japan TA - Gan To Kagaku Ryoho JT - Gan to kagaku ryoho. Cancer & chemotherapy JID - 7810034 RN - 0 (Antineoplastic Agents, Alkylating) RN - U68WG3173Y (Carmustine) SB - IM MH - Antineoplastic Agents, Alkylating/administration & dosage/adverse effects/*therapeutic use MH - Brain Neoplasms/*drug therapy/surgery MH - Carmustine/administration & dosage/adverse effects/*therapeutic use MH - Glioma/*drug therapy/surgery MH - Humans MH - Surveys and Questionnaires EDAT- 2016/05/24 06:00 MHDA- 2016/07/22 06:00 CRDT- 2016/05/24 06:00 PHST- 2016/05/24 06:00 [entrez] PHST- 2016/05/24 06:00 [pubmed] PHST- 2016/07/22 06:00 [medline] PST - ppublish SO - Gan To Kagaku Ryoho. 2016 May;43(5):603-7.